Given that defects in cholinergic neurotransmission are linked to AD, cholinesterase inhibitors such as galantamine, donepezil, rivastigmine, and huperzine A have been extensively studied as symptomatic treatments for AD [11, 12]. The gene discussed is BCHE; the disease is Alzheimer disease.